McKesson Current Ratio 2010-2024 | MCK

Current and historical current ratio for McKesson (MCK) from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. McKesson current ratio for the three months ending September 30, 2024 was 0.91.
McKesson Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2024-09-30 $53.34B $58.77B 0.91
2024-06-30 $52.25B $56.43B 0.93
2024-03-31 $47.97B $52.36B 0.92
2023-12-31 $47.64B $51.66B 0.92
2023-09-30 $47.53B $51.15B 0.93
2023-06-30 $45.54B $48.42B 0.94
2023-03-31 $44.29B $47.96B 0.92
2022-12-31 $44.66B $48.01B 0.93
2022-09-30 $46.45B $48.36B 0.96
2022-06-30 $45.38B $47.20B 0.96
2022-03-31 $46.23B $48.47B 0.95
2021-12-31 $46.50B $47.45B 0.98
2021-09-30 $45.58B $46.08B 0.99
2021-06-30 $43.35B $43.84B 0.99
2021-03-31 $45.38B $44.10B 1.03
2020-12-31 $42.37B $41.93B 1.01
2020-09-30 $42.35B $42.72B 0.99
2020-06-30 $38.68B $38.60B 1.00
2020-03-31 $42.22B $42.62B 0.99
2019-12-31 $39.39B $40.06B 0.98
2019-09-30 $37.35B $37.15B 1.01
2019-06-30 $38.43B $37.95B 1.01
2019-03-31 $38.47B $37.63B 1.02
2018-12-31 $38.32B $37.42B 1.02
2018-09-30 $38.54B $38.86B 0.99
2018-06-30 $38.21B $38.35B 1.00
2018-03-31 $37.14B $36.69B 1.01
2017-12-31 $40.20B $37.65B 1.07
2017-09-30 $39.79B $37.77B 1.05
2017-06-30 $37.70B $35.80B 1.05
2017-03-31 $36.95B $35.61B 1.04
2016-12-31 $39.27B $38.17B 1.03
2016-09-30 $41.34B $37.05B 1.12
2016-06-30 $39.04B $36.57B 1.07
2016-03-31 $38.44B $35.07B 1.10
2015-12-31 $38.26B $34.48B 1.11
2015-09-30 $38.75B $34.78B 1.11
2015-06-30 $38.57B $34.67B 1.11
2015-03-31 $36.67B $33.50B 1.10
2014-12-31 $37.14B $32.78B 1.13
2014-09-30 $33.88B $29.34B 1.16
2014-06-30 $33.97B $29.25B 1.16
2014-03-31 $32.84B $29.62B 1.11
2013-12-31 $25.23B $21.90B 1.15
2013-09-30 $24.55B $21.38B 1.15
2013-06-30 $24.07B $21.48B 1.12
2013-03-31 $23.17B $21.36B 1.09
2012-12-31 $23.44B $20.21B 1.16
2012-09-30 $23.09B $20.75B 1.11
2012-06-30 $22.05B $20.10B 1.10
2012-03-31 $23.60B $21.69B 1.09
2011-12-31 $24.57B $20.72B 1.19
2011-09-30 $23.26B $19.85B 1.17
2011-06-30 $22.37B $19.14B 1.17
2011-03-31 $22.36B $18.73B 1.19
2010-12-31 $21.69B $19.69B 1.10
2010-09-30 $20.24B $16.39B 1.24
2010-06-30 $20.79B $16.89B 1.23
2010-03-31 $21.50B $17.01B 1.26
2009-12-31 $20.85B $16.92B 1.23
2009-09-30 $19.93B $16.42B 1.21
2009-06-30 $19.06B $15.94B 1.20
2009-03-31 $18.67B $15.61B 1.20
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $79.108B $308.951B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $64.745B 17.02
Cardinal Health (CAH) United States $29.487B 15.99
West Pharmaceutical Services (WST) United States $22.928B 46.83
Cooper (COO) United States $20.075B 28.58
Labcorp (LH) United States $20.046B 16.62
Align Technology (ALGN) United States $16.863B 32.27
Henry Schein (HSIC) United States $9.361B 17.83
Merit Medical Systems (MMSI) United States $6.139B 31.35
DENTSPLY SIRONA (XRAY) United States $3.731B 10.15
CONMED (CNMD) United States $2.314B 19.31
Patterson (PDCO) United States $1.803B 9.52
STAAR Surgical (STAA) United States $1.315B 48.51
Lifevantage (LFVN) United States $0.178B 23.67
Pro-Dex (PDEX) United States $0.152B 30.36